Why 30 Years of Trial Innovation Keeps Hitting the Same Wall

Episode 37

0:00-43:59

Scott Schliebner on DCTs, Patient-Centric Trials & 30 Years of Pharma Innovation | Pharma Prescribed Scott Schliebner — founder of Ascent Biostrategies and veteran of nearly 30 years across biotech, CROs and nonprofit life sciences — joins Adam Walker for a candid, longitudinal view of how drug development actually evolves. And how often it refuses to. From being one of the first to transition a clinical team from paper CRFs to electronic data capture, to building DCT infrastructure at PRA Health Sciences before COVID made it suddenly essential, Scott has watched innovation after innovation hit the wall of a deeply conservative industry. His verdict? Patching on technology doesn't work. What does is putting patients in the room before the protocol is written.

Publisher

Adam Walker’s Pharma Prescribed Podcast

Link

pharmaprescribed.podbean.com/e/pharma-prescribed-with-scott-schliebner-healthcares-unseen-heroes-the-technological-shift/

Published

March 13, 2026

Duration

44 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Adam Walker

AW

Adam Walker’s Pharma Prescribed Podcast

@adamwalkerspharmaprescribedp

#years #trialinnovationkeeps #wall #lifesciences #management

The Nile